Table 4 Indication, use and assessment of aminoglycosides in patients with S. aureus IE (infective endocarditis) according to methicillin susceptibility
|  | IE due to MSSA (n = 17) | IE due to MRSA (n = 9) | p |
|---|---|---|---|
Indication of aminoglycosides | 15 (88.2) | 9 (100) | = 0.28 |
Delivery of aminoglycosides | 14 (82.3) | 4 (44.4) | <  0.05 |
Use of aminoglycosides in patients with indication | 12 (70.6) | 4 (44.4) | = 0.18 |
Aminoglycosides conformity | 12 (70.6) | 4 (44.4) | = 0.18 |
Number of deaths | 2 (11.8) | 3 (33.3) | = 0.18 |